Macter International Limited (PSX:MACTER)
245.38
-1.80 (-0.73%)
At close: Oct 16, 2026
Macter International Revenue
In the fiscal year ending June 30, 2026, Macter International had annual revenue of 12.17B PKR with 17.46% growth. Macter International had revenue of 2.89B in the quarter ending June 30, 2026, with 7.99% growth. That makes Macter International the 28,848th largest company in the world by revenue and 196th in Pakistan.
Revenue
12.17B
Revenue Growth
+17.46%
P/S Ratio
0.92
Revenue / Employee
8.40M
Employees
1,449
Market Cap
11.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 12.17B | 1.81B | 17.46% |
| Jun 30, 2025 | 10.36B | 2.39B | 29.91% |
| Jun 30, 2024 | 7.97B | 1.05B | 15.14% |
| Jun 30, 2023 | 6.93B | 1.31B | 23.42% |
| Jun 30, 2022 | 5.61B | 239.05M | 4.45% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 77.02B |
| GlaxoSmithKline Pakistan | 67.12B |
| The Searle Company | 36.81B |
| Highnoon Laboratories | 28.50B |
| AGP Limited | 27.70B |
| Ferozsons Laboratories | 23.96B |
| Citi Pharma | 14.08B |
| Otsuka Pakistan | 4.11B |